Sphere Fluidics appoints Edward Rayner as Non-Executive Director

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Ed Rayner to its Board of Directors as a Non-Executive Director.

China’s NMPA approves Antengene’s XPOVIO for DLBCL treatment

One of the most prevalent subtypes of adult non-Hodgkin lymphoma is diffuse large B-cell lymphoma. Credit: Nemes Laszlo/ Shutterstock. China’s National Medical Products Administration (NMPA)

July 8, 2024

MorphoSys AG Reports First Quarter 2024 Financial Results – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement MorphoSys AG Reports First Quarter 2024 Financial Results 29.04.2024 / 22:01 CET/CEST The issuer is

April 30, 2024

Trial Suggests Optimal Approach to Unresectable CRC Liver Mets

For patients with initially unresectable colorectal cancer liver metastases, FOLFOXIRI plus bevacizumab (Avastin) was the “preferred” systemic induction regimen for those with a right-sided or

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.